Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$68,628
-$11,400 QoQ
Shares Held
2,850
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#2,585
of 2,821 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kings Path Partners LLC holds $684,839 across 5 Drug Manufacturers - General names. PFE ranks #3 (10.0% of the industry book) .
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,628 | 2,850 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $80,028 | 2,850 | Shares | Sole | 2026-08-21 | |
| 2025-12-31 | $70,965 | 2,850 | Shares | Sole | 2026-07-14 | |
| 2025-09-30 | $75,166 | 2,950 | Shares | Sole | 2026-07-13 | |
| 2025-06-30 | $69,084 | 2,850 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $72,219 | 2,850 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $75,610 | 2,850 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $82,479 | 2,850 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $79,743 | 2,850 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||